Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis

Abroad (travel likely)RecruitingPHASE2

Conditions

Ulcerative Colitis · Inflammatory Bowel Diseases

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Oddział Kliniczny Gastroenterologii Ogólnej i Onkologicznej USK nr 1 im. N. Barlickiego w Łodzi, Lodz, Poland
Contact: Study coordinator (Adam Fabisiak, PhD) · adam.fabisiak@umed.lodz.pl · +48426776667

Study leads

Renata Talar-Wojnarowska, Prof.
Principal Investigator
Medical University of Lodz

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Subcutaneous Infliximab After A Previous Intravenous Dose Optimization

Inflammatory Bowel Diseases · Crohn Disease · Ulcerative Colitis

Abroad (travel likely)RecruitingPHASE4

Ghent, Belgium · Ostend, Belgium

Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population

Ulcerative Colitis · Inflammatory Bowel Diseases · Clostridioides Difficile Infection

Abroad (travel likely)RecruitingPHASE1

Calgary, Canada · Edmonton, Canada

Nutrition and Clinical Outcomes in IBD

Inflammatory Bowel Diseases · Crohn Disease · Ulcerative Colitis

Abroad (travel likely)Recruiting

London, United Kingdom

Genome Analysis Across Populations in Inflammatory Bowel Disease

Ulcerative Colitis · Healthy · Crohn Disease

Abroad (travel likely)Recruiting

Toronto, Canada